25dkg27 10.3205/25dkg27 urn:nbn:de:0183-25dkg273 Meeting Abstract Schröder Schröder Carolin C

Uniklinik Bonn, Bonn, Germany

author Saleh Saleh Murad M

GFO Kliniken Bonn, Bonn, Germany

author Tascón Padrón Tascón Padrón Laura L

Uniklinik Bonn, Bonn, Germany

author Pantenburg Pantenburg Jakob Friedemann JF

Uniklinik Bonn, Bonn, Germany

author Egger Egger Eva-Katharina EK

Uniklinik Bonn, Bonn, Germany

author Mustea Mustea Alexander A

Uniklinik Bonn, Bonn, Germany

author Könsgen-Mustea Könsgen-Mustea Dominique D

Uniklinik Bonn, Bonn, Germany

author German Medical Science GMS Publishing House

Düsseldorf

610 20251111 engl This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). M0612 27 Deutsche Kontinenz Gesellschaft e.V. 36. Kongress der Deutschen Kontinenz Gesellschaft Sitzung 12: Joint Session: spezielle Probleme in der Uro-Gynäkologie Bielefeld 20251114 20251115 27 TextIntroduction: Stress urinary incontinence (SUI) is a common condition affecting up to 50% of older women and 20–30% of premenopausal women, significantly impacting quality of life. While Burch colposuspension (BC) has shown long-term efficacy rates of 65–90%, up to 28% of patients (pts) experience adverse events.Methods: This study assessed BC procedures performed via mini-laparotomy (2020–2023) by a single urogynecological surgeon at University Hospital Bonn. The study aimed to determine the effect of BC for the treatment of SUI in women. Objective outcomes included a stress test and 24-hour pad usage, while subjective outcomes were evaluated using the German Pelvic Floor Questionnaire (GPFQ) and the International Consultation of Incontinence Questionnaire (ICIQ).Follow-up examinations were performed at 8-12 weeks (FU1) and at the timing of last clinical follow-up (FU2a). A study-specific questionnaire (SSQ), GPFQ and ICIQ were sent to all pts between December 2023 and May 2024 (FU2b). Secondary aims were to assess the safety of BC and identify predictors of surgical failure.Results: Among 115 BC procedures, the domains bladder, prolapse and sexual function regarding GPFQ were significantly reduced at FU1 compared to preoperatively. 81% of pts showed improvement or cure (ICIQ) at FU2a (mean 16 months). The positive stress test rate dropped significantly (22% to 3.5%, p < 0.05), as did pad usage (3 to 1, p = 0.05) between preoperatively and FU2a. At FU2a, 15.7% had persistent SUI, 23.5% reported urge symptoms, and bladder, prolapse, and sexual function regarding GPFQ improved significantly. At FU2b (mean 22 months), 81% were satisfied, and de novo urge symptoms occurred in 3.5%. Low preoperative urethral closure pressure was linked to higher failure risk.Conclusion: BC is an effective treatment modality for SUI in women, offering high patient satisfaction, good short-term treatment success, and a low risk of adverse events. Sussman RD Syan R Brucker BM Guideline of guidelines: urinary incontinence in women 2020 BJU Int 638-55 Sussman RD, Syan R, Brucker BM. Guideline of guidelines: urinary incontinence in women. BJU Int. 2020 May;125(5):638-55. Lapitan MCM Cody JD Mashayekhi A Open retropubic colposuspension for urinary incontinence in women 2017 Cochrane Database Syst Rev CD002912 Lapitan MCM, Cody JD, Mashayekhi A. Open retropubic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev. 2017;7:CD002912. Veit‐Rubin N Dubuisson J Ford A Dubuisson J Mourad S Digesu A Burch colposuspension 2019 Neurourol Urodyn 553-62 Veit‐Rubin N, Dubuisson J, Ford A, Dubuisson J, Mourad S, Digesu A. Burch colposuspension. Neurourol Urodyn. 2019 Feb;38(2):553-62. 0 0 0 0